Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

TGF-β2 plays a key role in human hair growth and development.

Finasteride may cause suicidal thoughts and mental side effects, especially in young people with hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Consider benefits and risks of new alopecia treatments for safety.

DA-9401 helps protect rat testis from finasteride damage.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Certain drugs change freshwater snail shells to a "banana" shape.

Combination therapies work better than single treatments for hair loss.